Xuan Cao, MD
Ophthalmology · Montebello
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 8 years
- Drexel University College of Medicine, 2018
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cao’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$5,976
Medicare paid this office $5,976 for 40 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 12 | $1,715 | $143 |
| Established patient complete exam of visual system | 15 | $1,558 | $104 |
| Established patient problem focused exam of visual system | 13 | $1,187 | $74 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
40 Original Medicare patients in 2024. Average age 71 · Women 70% · Health risk score 2.12. Sicker patients than 9 in 10 peers; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 70% · Depression 40% · Chronic kidney disease 38% · Coronary heart disease 33% · Heart failure 28%.
The office billed $17,638, Medicare allowed $8,210 and paid $5,976; for 73 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$3,796 in 2024
Medicaid paid $3,796 for 70 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 70 | $3,796 |
| 2024 | 70 | 1 | 26 | $3,796 |
| 2023 | 20 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 20 | $0 |
Drugs they prescribed that Part D paid
$30,642
Pharmacies billed $30,642 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 129) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
77 generic and 52 brand-name prescriptions · $30,642 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Brimonidine | 12 | $857 | $71 |
| Dorzolamide-Timolol | 21 | $295 | $14 |
| Latanoprost | 32 | $271 | $8 |
Year by year
| 2024 | 129 | 47 | 0% (0) | 40% | $30,642 |
| 2023 | 201 | 52 | 0% (0) | 41% | $33,916 |
| 2022 | 129 | 36 | 0% (0) | 40% | $6,307 |
| 2021 | 63 | 21 | 0% (0) | 33% | $2,936 |
| 2019 | 68 | 21 | 0% (0) | None | $2,688 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Brimonidine | 25 | $3,389 | $136 |
| Dorzolamide-Timolol | 38 | $1,108 | $29 |
| Prednisolone Acetate | 15 | $1,098 | $73 |
| Latanoprost | 65 | $767 | $12 |
| Ketorolac Tromethamine | 12 | $323 | $27 |
2022: 4 drugs
| Brimonidine | 16 | $1,283 | $80 |
| Prednisolone Acetate | 27 | $1,270 | $47 |
| Dorzolamide-Timolol | 19 | $523 | $28 |
| Latanoprost | 29 | $276 | $10 |
2021: 2 drugs
| Prednisolone Acetate | 12 | $716 | $60 |
| Latanoprost | 11 | $101 | $9 |
2019: 1 drug
| Latanoprost | 22 | $192 | $9 |
Money from drug and device companies
$149 in 2025
| 2025 | 1 | 1 | None | $149 |
| 2024 | 1 | 1 | None | $34 |
| 2023 | 2 | 2 | None | $279 |
| 2022 | 5 | 14 | None | $832 |
| 2021 | 3 | 4 | None | $274 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Clareon Panoptix Pro | $149 | 1 payment
|
See the published payment
| Alcon Vision | Meals · 2025-08-05 | Clareon Panoptix Pro | $149 |
See earlier years (2024, 2023, 2022, 2021)
2024: $34
| Alcon Vision | Rocklatan | $34 | 1 payment
|
2023: $279
| Alimera Sciences | Iluvien | $144 | 1 payment
|
| Alcon Vision | Hydrus Microstent | $135 | 1 payment
|
2022: $832
| Alcon Vision | Clareon | $542 | 8 payments
|
| Apellis Pharmaceuticals | None | $124 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $97 | 2 payments
|
| Bausch & Lomb Americas | Xipere | $44 | 2 payments
|
| Glaukos | Istent Inject W | $24 | 1 payment
|
2021: $274
| Regeneron Healthcare Solutions | Eylea | $125 | 1 payment
|
| Alimera Sciences | Iluvien | $119 | 1 payment
|
| Alcon Vision | Acrysof | $30 | 2 payments
|
Professional record
- NPI
- 1386139673
- Licence
- MD D98025
- Trained
- Drexel University College of Medicine, 2018 · 8 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 2446 W Whittier Blvd, Montebello, CA, 90640
- NPI first listed
- 2018-06-28
- NPI last updated
- 2024-09-27
- NPI record certified
- 2024-09-27
This is when the NPI record was last certified, not a medical board exam.